Research Seed Grant Program
Through its diverse and multidisciplinary membership, the Canadian Fertility and Andrology Society possesses a wealth of expertise in the areas of basic sciences, medicine, and social sciences. Within this diverse community, the CFAS recognizes an enormous potential for original research and innovation through cross-discipline collaboration. For this reason, the CFAS established an endowment fund to promote new and innovative research in the area of reproduction, particularly where the research involves collaboration between people working in different disciplines.
The ‘Seed Grant’ program provides financial assistance to initiate new research or to obtain preliminary results needed to begin a new a research program that could subsequently be funded by regular grant agencies. Although the program primarily targets interactions between basic scientists and clinicians, collaborations for other interdisciplinary projects will also be considered.
Criteria for Selection
To be included in the judging, proposals must demonstrate that the research project involves collaboration between two or more primary investigators who work in different locations and who represent clearly distinct disciplines.
Proposals will be judged on the following criteria:
- Quality of the scientific/research idea (20%)
- Originality of the idea (20%)
- The chances of success (20%)
- The value of the results to be obtained (20%)
- Qualification of the co-applicants (20%)
A sub-committee of the CFAS Board of Directors will review all applications. The sub-committee shall consist of at least one member from the Board of Directors and shall include at least one basic scientist and one clinician. Proposals will be ranked according to the evaluation criteria outlined above. Successful applicants will be awarded funding subject to annual budgetary limits. Primary Investigators must be CFAS members in good standing.
Funding Available in 2018
3 Seed Grants of $5,000 each.
Applications must be received at the CFAS office before June 30th for consideration in the current year. Successful applicants will be notified by September 1st and announced publicly at the CFAS Annual Meeting.
Applications must conform to the instructions below:
- Individual applicants may only submit one proposal per year.
- Applicants must submit a mid-year report upon request from the Board of Directors
- The results of research projects must be submitted as an abstract and presented to the CFAS Annual Meeting of the following year. If absolutely no results are available for submission and presentation, a one page report explaining the reasons must be sent to the CFAS Board.
- Applications are to be submitted on letter size (8.5 x 11 inches) paper, using 12 point Arial font, and be no longer than 2 pages, with the following format:
Include the following elements your application:
Principal Investigator (name, affiliations, primary place of work/employment)
Co-Investigator(s) (name, affiliations, primary place of work/employment)
Hypotheses to be tested, aim(s) of research and significance of research to the field of human reproduction and fertility
Experimental design (if pertinent)
- Include study design (if pertinent)
- Include patient inclusion and exclusion criteria (if pertinent)
- Include number of patients, oocytes, embryos etc. (if pertinent)
- Include brief description of methodology
- Include endpoints of project and time line for milestones
Value of the information, including:
- To the scientist (e.g, preliminary results for a grant)
- To the clinic/physicians, embryologist, nurse etc..
- To the patient (population)
Ethics approval requirements (if required, funding will be held until proof of approval is received)
Budget (on a third page)
Short CVs (max 2 pages each) for each principal applicant and co-applicant. For the Principal and Co-Investigator, you must demonstrate that you meet the requirement for cross discipline collaboration. Please indicate the following:
- Primary career focus (i.e: clinical care, biomedical research, etc.)
- Primary work location (be specific—university research lab, ART clinic, etc.)